Literature DB >> 22527814

Acquired rhinophyma as a paraneoplastic manifestation of non-small cell lung cancer.

Neven Rakusic1, Denis Baricevic, Nevena Rakusic, Miroslav Samarzija, Marko Jakopovic, Marinka Baricevic.   

Abstract

We report a case of a 58-year-old man who developed rhinophyma caused by non-small cell lung cancer. To the best of our knowledge, rhinophyma as paraneoplastic syndrome associated with non-small cell lung cancer has not been previously reported.

Entities:  

Mesh：

Year:  2012        PMID： 22527814     DOI： 10.1007/s00508-012-0151-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


  5 in total

1.  Paraneoplastic opsoclonus-myoclonus ataxia associated with non-small-cell lung carcinoma.

Authors:  Kiran Musunuru; Santosh Kesari
Journal:  J Neurooncol       Date:  2008-07-11       Impact factor: 4.130

Review 2.  Present strategy of lung cancer screening and surgical management.

Authors:  Norihiko Ikeda; Aeru Hayashi; Yoshifumi Miura; Tetsuya Okunaka; Ken Okuzawa; Masahiro Tsuboi; Yasufumi Kato; Yasuhiro Suga; Harubumi Kato
Journal:  Ann Thorac Cardiovasc Surg       Date:  2005-12       Impact factor: 1.520

3.  Isolated knee monoarthritis heralding resectable non-small-cell lung cancer. A paraneoplastic syndrome not previously described.

Authors:  Fabrizio Cantini; Laura Niccoli; Carlotta Nannini; Daniela Chindamo; Michele Bertoni; Emanuele Cassarà; Carlo Salvarani
Journal:  Ann Rheum Dis       Date:  2007-09-03       Impact factor: 19.103

4.  Paraneoplastic Raynaud phenomenon and idiopathic thrombocytopenic purpura in non-small-cell lung cancer.

Authors:  Alvin S C Wong; Kam Hon Yoon
Journal:  Am J Clin Oncol       Date:  2003-02       Impact factor: 2.339

5.  Large bilateral adrenal metastases in non-small cell lung cancer.

Authors:  Charisios Karanikiotis; Apostolos Anto Tentes; Sotirios Markakidis; Konstantinos Vafiadis
Journal:  World J Surg Oncol       Date:  2004-11-13       Impact factor: 2.754
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.